MONOLISA ANTI-HBS EIA

FDA Premarket Approval P050048

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the monolisa anti-hbs eia and the monolisa anti-hbs calibrator kit. The devices are indicated for: the monolisa anti-hbs eia is a qualitative and quantitative enzyme immunoassay for the detection of antibody to hepatitis b surface antigen in human serum and edta or citrated plasma. The assay results may be used as an aid in the determination of susceptibility to hepatitis b virus (hbv) infection in individuals prior to or following hbv vaccination or where vaccination status is unknown. Assay results may be used with other hbv serological markers for the laboratory diagnosis of hbv disease associated with hbv infection. A reactive assay result will allow a differential diagnosis in individuals displaying signs and symptoms of hepatitis in whom etiology is unknown. The monolisa anti-hbs calibrator kit is intended for quantitative determination of anti-hbs in human serum and edta or citrated plasma. The monolisa anti-hbs calibrator kit is to be used only with the monolisa anti-hbs eia.

DeviceMONOLISA ANTI-HBS EIA
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantBIO-RAD LABORATORIES
Date Received2005-12-05
Decision Date2006-08-25
Notice Date2007-04-19
PMAP050048
SupplementS
Product CodeLOM 
Docket Number07M-0151
Advisory CommitteeMicrobiology
Expedited ReviewNo
Combination Product No
Applicant Address BIO-RAD LABORATORIES 6565 185th Ave, Ne redmond, WA 98052
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P050048Original Filing
S009 2013-11-13 30-day Notice
S008 2012-10-19 30-day Notice
S007 2012-02-22 135 Review Track For 30-day Notice
S006 2010-06-18 135 Review Track For 30-day Notice
S005 2010-06-17 Normal 180 Day Track No User Fee
S004 2009-09-28 Normal 180 Day Track
S003
S002 2008-09-30 Real-time Process
S001 2008-07-01 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00847865002110 P050048 000
00847865002103 P050048 000
00847865002097 P050048 000
00847865002080 P050048 000
00847865002073 P050048 000
00847865002066 P050048 000
00847865002059 P050048 000
00847865002042 P050048 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.